Biomarker in Lung Diseases

H

Heidelberg University

Status

Unknown

Conditions

Lung Diseases

Treatments

Other: biomarker

Study type

Observational

Funder types

Other

Identifiers

NCT00989846
MK02

Details and patient eligibility

About

Disease related biomarkers have been established decades ago, e.g. blood glucose for diabetes diagnosis and management. Their discovery has grown dramatically during the past decade and they have the potential to lead the physician in diagnosis -especially differential diagnosis - and therapy. However, a specific serum-biomarker in lung diseases has not been established. Aim of the current study is to to measure lung specific proteins in the serum in patients with various lung diseases and to correlate those with disease severity, lung function and other laboratory results

Enrollment

120 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age >= 18
  • acute or chronic lung disease

Exclusion criteria

  • HIV
  • lactation or gestation

Trial design

120 participants in 1 patient group

lung disease
Description:
patients with various chronic or acute lung diseases
Treatment:
Other: biomarker

Trial contacts and locations

0

Loading...

Central trial contact

Michael Kreuter, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems